We are live on ! Find out more
BBP icon

Virtus Biotech ETF
BBP

15 hedge funds and large institutions have $4.32M invested in Virtus Biotech ETF in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more capital invested

Capital invested by funds: $4.29M → $4.32M (+$25K)

0% more funds holding

Funds holding: 15 → 15 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

Holders
15
Holders Change
–
Holders Change %
0%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VFS
VSR Financial Services
Kansas
+$948K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$468K
3
VKH
Virtu KCG Holdings
New York
+$322K
4
MFS
MSI Financial Services
Massachusetts
+$2.73K
5
FWM
Focused Wealth Management
New York
+$2.43K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$569K
2
LPL Financial
LPL Financial
California
-$223K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$53.3K
4
Citadel Advisors
Citadel Advisors
Florida
-$43.5K
5
UBS Group
UBS Group
Switzerland
-$37K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$1.08M +$468K +19,221 +79%
VFS
2
VSR Financial Services
Kansas
$961K +$948K +38,980 New
LPL Financial
3
LPL Financial
California
$875K -$223K -9,182 -21%
VKH
4
Virtu KCG Holdings
New York
$561K +$322K +13,232 +139%
Jane Street
5
Jane Street
New York
$432K -$569K -23,392 -57%
Citadel Advisors
6
Citadel Advisors
Florida
$216K -$43.5K -1,787 -17%
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
$131K -$53.3K -2,190 -29%
LTFS
8
Ladenburg Thalmann Financial Services
Florida
$17K – – –
FWM
9
Focused Wealth Management
New York
$17K +$2.43K +100 +17%
AIG
10
American International Group
New York
$13K – – –
CFA
11
Carroll Financial Associates
North Carolina
$6K – – –
Creative Planning
12
Creative Planning
Kansas
$5K – – –
TRCT
13
Tower Research Capital (TRC)
New York
$4K -$18K -739 -83%
MFS
14
MSI Financial Services
Massachusetts
$3K +$2.73K +112 New
Morgan Stanley
15
Morgan Stanley
New York
$2K – – –
UBS Group
16
UBS Group
Switzerland
– -$37K -1,213 Closed
Citigroup
17
Citigroup
New York
– -$1K -41 Closed

BBP Hedge Fund Activity: Q1 2016 in Review

15 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q1 2016, worth a combined $4.32M — up 0.58% from $4.29M a quarter earlier.

Fund positioning in BBP was balanced in Q1 2016: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 5 trimmed.

The largest buyer was VSR Financial Services, opening a new position worth an estimated $948K. The largest seller was Jane Street, cutting an estimated $569K.

  • 15 institutional investors held Virtus Biotech ETF (BBP) as of Q1 2016, unchanged from Q4 2015.
  • Funds reported $4.32M of Virtus Biotech ETF stock for Q1 2016, up 0.58% quarter-over-quarter.
  • 2 funds opened new Virtus Biotech ETF positions in Q1 2016 and 2 closed out, a net change of 0 holders.
  • The largest Virtus Biotech ETF buyer in Q1 2016 was VSR Financial Services, an estimated $948K added.
  • The largest Virtus Biotech ETF seller in Q1 2016 was Jane Street, an estimated $569K sold.

Based on aggregated 13F filings for Q1 2016.